Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 13, 2026

Murine Bilateral Renal Lymphadenectomy
06:31

Murine Bilateral Renal Lymphadenectomy

Published on: December 30, 2025

Bilateral Wilms' tumour in a developing country: a descriptive study.

G P Hadley1, M Mars, P K Ramdial

  • 1Department of Paediatric Surgery, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa. hadley@ukzn.ac.za

Pediatric Surgery International
|March 5, 2013
PubMed
Summary

Bilateral Wilms' tumour is treatable even in resource-limited settings. This study highlights successful outcomes in children with this rare cancer, emphasizing the importance of tailored treatment strategies.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterizations of Kerr-de Sitter in arbitrary dimension from null infinity.

Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2024
Same author

Members of Ensifer and Rhizobium genera are new bacterial endosymbionts nodulating Pisum sativum (L.).

FEMS microbiology ecology·2023
Same author

Dos and don'ts for mHealth-based clinical support among clinicians in South Africa: Results from a 1-day workshop.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2021
Same author

The implementation of a national paediatric oncology protocol for neuroblastoma in South Africa.

Cancer causes & control : CCC·2021
Same author

Age at diagnosis as a prognostic factor in South African children with neuroblastoma.

Pediatric blood & cancer·2021
Same author

The need for a telemedicine strategy for Botswana? A scoping review and situational assessment.

BMC health services research·2020

Area of Science:

  • Pediatric Oncology
  • Nephrology
  • Surgical Oncology

Background:

  • Bilateral Wilms' tumour is a rare pediatric malignancy.
  • Management in resource-constrained environments presents unique challenges.
  • Understanding outcomes in diverse settings is crucial for global health equity.

Purpose of the Study:

  • To report the experience of managing 20 children with bilateral Wilms' tumour.
  • To analyze treatment outcomes in a resource-challenged setting over a decade.
  • To assess the feasibility of treating this rare condition under limitations.

Main Methods:

  • Retrospective review of patients diagnosed with bilateral synchronous Wilms' tumour.
  • Analysis of clinical presentation, treatment modalities, and survival data.

Related Experiment Videos

Last Updated: May 13, 2026

Murine Bilateral Renal Lymphadenectomy
06:31

Murine Bilateral Renal Lymphadenectomy

Published on: December 30, 2025

  • Evaluation of surgical approaches and histopathological findings.
  • Main Results:

    • Bilateral Wilms' tumour represented 11% of all Wilms' tumour cases.
    • 20% of patients presented with metastatic disease; others had specific complications.
    • Nephron-sparing surgery was performed in 22 kidneys; 2-year overall survival was 85%.

    Conclusions:

    • Bilateral Wilms' tumour can be effectively treated despite significant comorbidities and advanced disease.
    • Resource-constrained environments can achieve favorable outcomes with appropriate management.
    • This study underscores the treatability of Wilms' tumour globally.